Maria L. Ascierto, Ph.D. Saint John's Cancer Institute

Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.

Cancers, Free Full-Text

Melanoma and Cutaneous Oncology - Saint John's Cancer Institute

Dr. Kim Margolin, MD, Duarte, CA, Oncologist

Cabrini Research Annual Report 2020-21 by Cabrini Health - Issuu

Upper Gastrointestinal & Endocrine Tumors - VHIO

Translational Research Departments - Santa Monica, CA

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - ScienceDirect

Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma

Abstracts For The 27th Annual Scientific Meeting of The Society For Immunotherapy of Cancer (SITC) PDF, PDF, T Cell

Previous Issues - JADPRO

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - Journal of Thoracic Oncology

Resolving Cancer Heterogeneity: - PDF Free Download

Melanoma/Skin Cancer Treatment Center - Santa Monica, CA

Upper Gastrointestinal & Endocrine Tumors - VHIO